323 related articles for article (PubMed ID: 31361359)
21. Atypical presentation of rapid-onset dystonia-parkinsonism in a toddler with a novel mutation in the ATP1A3 gene.
Ganesh A; Sivakumar S; Manokaran R; Narasimhan U
BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34413044
[TBL] [Abstract][Full Text] [Related]
22. Paying the price at the pump: dystonia from mutations in a Na+/K+ -ATPase.
Cannon SC
Neuron; 2004 Jul; 43(2):153-4. PubMed ID: 15260948
[TBL] [Abstract][Full Text] [Related]
23. A C-terminal mutation of ATP1A3 underscores the crucial role of sodium affinity in the pathophysiology of rapid-onset dystonia-parkinsonism.
Blanco-Arias P; Einholm AP; Mamsa H; Concheiro C; Gutiérrez-de-Terán H; Romero J; Toustrup-Jensen MS; Carracedo A; Jen JC; Vilsen B; Sobrido MJ
Hum Mol Genet; 2009 Jul; 18(13):2370-7. PubMed ID: 19351654
[TBL] [Abstract][Full Text] [Related]
24. Genome sequencing identifies a novel mutation in ATP1A3 in a family with dystonia in females only.
Wilcox R; Brænne I; Brüggemann N; Winkler S; Wiegers K; Bertram L; Anderson T; Lohmann K
J Neurol; 2015 Jan; 262(1):187-93. PubMed ID: 25359261
[TBL] [Abstract][Full Text] [Related]
25. ATP1A3 spectrum disorders: A video-documented history of 7 genetically confirmed early onset cases.
Stagnaro M; Pisciotta L; Gherzi M; Di Rocco M; Gurrieri F; Parrini E; Prato G; Veneselli E; De Grandis E
Eur J Paediatr Neurol; 2018 Mar; 22(2):264-271. PubMed ID: 29396171
[TBL] [Abstract][Full Text] [Related]
26. Mosaicism in ATP1A3-related disorders: not just a theoretical risk.
Hully M; Ropars J; Hubert L; Boddaert N; Rio M; Bernardelli M; Desguerre I; Cormier-Daire V; Munnich A; de Lonlay P; Reilly L; Besmond C; Bahi-Buisson N
Neurogenetics; 2017 Jan; 18(1):23-28. PubMed ID: 27726050
[TBL] [Abstract][Full Text] [Related]
27. A case of rapid-onset dystonia-parkinsonism accompanied by pyramidal tract impairment.
Liu Y; Lu Y; Zhang X; Xie S; Wang T; Wu T; Wang C
BMC Neurol; 2016 Nov; 16(1):218. PubMed ID: 27835968
[TBL] [Abstract][Full Text] [Related]
28. Asystole in alternating hemiplegia with de novo ATP1A3 mutation.
Novy J; McWilliams E; Sisodiya SM
Eur J Med Genet; 2014 Jan; 57(1):37-9. PubMed ID: 24291144
[TBL] [Abstract][Full Text] [Related]
29. Auditory-perceptual voice and speech evaluation in ATP1A3 positive patients.
Moya-Mendez ME; Madden LL; Ruckart KW; Downes KM; Cook JF; Snively BM; Brashear A; Haq IU
J Clin Neurosci; 2020 Nov; 81():133-138. PubMed ID: 33222902
[TBL] [Abstract][Full Text] [Related]
30. ATP1A3 mutation in the first asian case of rapid-onset dystonia-parkinsonism.
Lee JY; Gollamudi S; Ozelius LJ; Kim JY; Jeon BS
Mov Disord; 2007 Sep; 22(12):1808-9. PubMed ID: 17595045
[TBL] [Abstract][Full Text] [Related]
31. Dystonia-plus syndromes.
Asmus F; Gasser T
Eur J Neurol; 2010 Jul; 17 Suppl 1():37-45. PubMed ID: 20590807
[TBL] [Abstract][Full Text] [Related]
32. Psychiatric disorders in rapid-onset dystonia-parkinsonism.
Brashear A; Cook JF; Hill DF; Amponsah A; Snively BM; Light L; Boggs N; Suerken CK; Stacy M; Ozelius L; Sweadner KJ; McCall WV
Neurology; 2012 Sep; 79(11):1168-73. PubMed ID: 22933743
[TBL] [Abstract][Full Text] [Related]
33. Heterozygous mice deficient in Atp1a3 exhibit motor deficits by chronic restraint stress.
Sugimoto H; Ikeda K; Kawakami K
Behav Brain Res; 2014 Oct; 272():100-10. PubMed ID: 24983657
[TBL] [Abstract][Full Text] [Related]
34. ATP1A3-related disorders: An update.
Carecchio M; Zorzi G; Ragona F; Zibordi F; Nardocci N
Eur J Paediatr Neurol; 2018 Mar; 22(2):257-263. PubMed ID: 29291920
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneity of presentation and outcome in the Irish rapid-onset dystonia-parkinsonism kindred.
McKeon A; Ozelius LJ; Hardiman O; Greenway MJ; Pittock SJ
Mov Disord; 2007 Jul; 22(9):1325-7. PubMed ID: 17516473
[TBL] [Abstract][Full Text] [Related]
36. ATP1A3-related phenotypes in Chinese children: AHC, CAPOS, and RECA.
Huang D; Song X; Ma J; Li X; Guo Y; Li M; Luo H; Fang Z; Yang C; Xie L; Jiang L
Eur J Pediatr; 2023 Feb; 182(2):825-836. PubMed ID: 36484864
[TBL] [Abstract][Full Text] [Related]
37. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood.
Heinzen EL; Swoboda KJ; Hitomi Y; Gurrieri F; Nicole S; de Vries B; Tiziano FD; Fontaine B; Walley NM; Heavin S; Panagiotakaki E; ; ; ; Fiori S; Abiusi E; Di Pietro L; Sweney MT; Newcomb TM; Viollet L; Huff C; Jorde LB; Reyna SP; Murphy KJ; Shianna KV; Gumbs CE; Little L; Silver K; Ptáček LJ; Haan J; Ferrari MD; Bye AM; Herkes GK; Whitelaw CM; Webb D; Lynch BJ; Uldall P; King MD; Scheffer IE; Neri G; Arzimanoglou A; van den Maagdenberg AM; Sisodiya SM; Mikati MA; Goldstein DB
Nat Genet; 2012 Sep; 44(9):1030-4. PubMed ID: 22842232
[TBL] [Abstract][Full Text] [Related]
38. Mutational and phenotypic expansion of ATP1A3-related disorders: Report of nine cases.
Boonsimma P; Michael Gasser M; Netbaramee W; Wechapinan T; Srichomthong C; Ittiwut C; Wagner M; Krenn M; Zimprich F; Abicht A; Biskup S; Roser T; Borggraefe I; Suphapeetiporn K; Shotelersuk V
Gene; 2020 Jul; 749():144709. PubMed ID: 32339621
[TBL] [Abstract][Full Text] [Related]
39. Alternating hemiplegia of childhood in Denmark: clinical manifestations and ATP1A3 mutation status.
Hoei-Hansen CE; Dali CÍ; Lyngbye TJ; Duno M; Uldall P
Eur J Paediatr Neurol; 2014 Jan; 18(1):50-4. PubMed ID: 24100174
[TBL] [Abstract][Full Text] [Related]
40. Novel ATP1A3 mutation in a sporadic RDP patient with minimal benefit from deep brain stimulation.
Kamm C; Fogel W; Wächter T; Schweitzer K; Berg D; Kruger R; Freudenstein D; Gasser T
Neurology; 2008 Apr; 70(16 Pt 2):1501-3. PubMed ID: 18413579
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
